Anti-Ki67 / MKI67 antibody

Anti-Ki67 / MKI67 antibody

• DataSheet
• Material Safety Data Sheets (MSDS)

Rabbit polyclonal to Ki67 / MKI67

IHC-P

Human Ki-67

KIA antibody; MIB- antibody; MIB-1 antibody; PPP1R105 antibody; Ki67 antibody; Ki-67 antibody; D630048A14Rik antibody; antigen KI-67 antibody; antigen KI-67 antibody; D630048A14Rik antibody; Ki67 antibody; Ki-67 antibody; KIA antibody; proliferation-related Ki-67 antigen antibody; RP11-380J17.2 antibody

Rabbit IgG

Produced in rabbits immunized with purified, a synthetic peptide corresponding to the sequence of the Human Ki-67, and purified by antigen affinity chromatography.

Polyclonal

0.2 μm filtered solution in PBS with 5% trehalose

This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

MKI67 contains 1 FHA domain and plays a key role in cell proliferation. During interphase, the MKI67 antigen can be exclusively detected within the cell nucleus, whereas in mitosis most of the protein is relocated to the surface of the chromosomes. MKI67 protein is present during all active phases of the cell cycle (G1, S, G2, and mitosis), but is absent from resting cells. MKI67 is an excellent marker to determine the growth fraction of a given cell population. The fraction of MKI67-positive tumor cells is often correlated with the clinical course of cancer. It is also associated with ribosomal RNA transcription. Inactivation of antigen MKI67 leads to inhibition of ribosomal RNA synthesis.The MKI67 protein is a nuclear and nucleolar protein, which is tightly associated with somatic cell proliferation. Antibodies raised against the human MKI67 protein paved the way for the immunohistological assessment of cell proliferation, particularly useful in numerous studies on the prognostic value of cell growth in clinical samples of human neoplasms. MKI67 protein expression is an absolute requirement for progression through the cell-division cycle. Recently, MKI67 is proved be an independent prognostic factor for disease-free survival (HR 1.05-1.72) in multivariate analyses studies using samples from randomized clinical trials with secondary central analysis of the biomarker. MKI67 was not found to be predictive for long-term follow-up after chemotherapy. Nevertheless, high KI-67 was found to be associated with immediate pathological complete response in the neoadjuvant setting, with an LOE of II-B. MKI67 could be considered as a prognostic biomarker for therapeutic decision.

• Rahmanzadeh R, et al. (2007) Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis. Cell Prolif. 40(3):422-30.
• Bullwinkel J, et al. (2006) Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol. 206(3):624-35.
• Schonk DM, et al. (1989) Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10. Hum Genet. 83(3):297-9.
• Endl E, et al., 2000, Exp Cell Res. Jun 15;257(2): 231-7.
• Luporsi E, et al., 2012, Breast Cancer Res Treat. 132(3): 895-915.
• Scholzen T, et al., 2000, J Cell Physiol. 182(3): 311-22.